Corporate Profile
Message
Business Operations
News
Contact us
JP
EN
News
May 10, 2018
Pharmaceuticals and Medical Devices Agency accepts the filing for YLB113, a biosimilar product of anti-rheumatoid arthritis biopharmaceutical Enbrel®
”read more” link to press release PDF.